Skip to main content
Hanmi Science Co.,Ltd logo

Hanmi Science Co.,Ltd — Investor Relations & Filings

Ticker · 008930 ISIN · KR7008930000 KO Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 008930

About Hanmi Science Co.,Ltd

https://www.hanmipharm.com/

Hanmi Science Co., Ltd. is a holding company that manages subsidiaries engaged in the pharmaceutical and healthcare sectors. Its principal operating subsidiary, Hanmi Pharmaceutical, is an R&D-centric biopharmaceutical company focused on the development of innovative new drugs. The group's integrated activities span from in-house research and development to the manufacturing and commercialization of a wide range of pharmaceutical products. A key strategic focus is the creation of novel therapies to address unmet medical needs, which are then provided to medical professionals.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 99% confidence The document is a detailed quarterly report (“분기보고서”) for the period January 1 to March 31, 2026, containing extensive financial statements, segment disclosures, production and sales data, and notes. It is the actual interim/quarterly report, not merely an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Regulatory Filings
2026-04-30 Korean
결산실적공시예고(안내공시)
Report Publication Announcement Classification · 85% confidence The document is a short notice (‘안내공시’) announcing the scheduled date (2026-04-30) for the publication of the Q1 2026 financial results. It does not contain the results themselves but simply informs investors of the timing of the upcoming report. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or availability of company reports.
2026-04-23 Korean
타인에대한채무보증결정(자회사의 주요경영사항)
Regulatory Filings
2026-04-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 96% confidence The document is a Korean “주식등의 대량보유상황보고서(일반)” – a large shareholding status report filed under the Capital Market Act, detailing the number of shares held, changes in holdings, and related contracts. It is not an earnings or annual report, nor a management or legal update, but a regulatory disclosure of major share ownership levels. This matches the definition for Major Shareholding Notification (Code: MRQ).
2026-04-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서” which translates to “Report on Holding of Specified Securities by Officers and Major Shareholders.” It details the share ownership and transactions of an officer (Shin Dong-guk) in Hanmi Science Co., Ltd., including share counts, percentages, and acquisition details for a specified date. This is a personal insider share transaction disclosure by a director/executive. Under our taxonomy, this aligns with Director's Dealing (DIRS).
2026-04-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.